Euroapi and priothera enter into cdmo collaboration to advance oncology project

Paris – june 18, 2024 – euroapi announces today the implementation of a 5-year development and manufacturing agreement with priothera, a biotechnology company specializing in molecules for the treatment of hematological malignancies and for the improvement of car-t cell therapies. priothera is headquartered in dublin, ireland, and has a subsidiary in saint-louis (haut-rhin), france.
CDMO Ratings Summary
CDMO Quant Ranking